1-4 of 4
Abdullah Alajati
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma

Open Access
Sana Hosni, Viola Kilian, Niklas Klümper, Daniela Gabbia, Katharina Sieckmann, Dillon Corvino, Anja Winkler, Miriam Saponaro, Karin Wörsdörfer, Doris Schmidt, Oliver Hahn, Ilaria Zanotto, Marina Bertlich, Marieta Toma, Tobias Bald, Markus Eckstein, Michael Hölzel, Matthias Geyer, Manuel Ritter, Dagmar Wachten, Sara De Martin, Abdullah Alajati
Journal: Cancer Research
Cancer Res (2024) 84 (5): 725–740.
https://doi.org/10.1158/0008-5472.CAN-23-1398
Published: 04 March 2024
View articletitled, Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma
Open the PDF for Adipocyte Precursor-Derived NRG1 Promotes Resistance to FGFR Inhibition in Urothelial Carcinoma in another window
Includes: Supplementary data
Journal Articles

Abstract 2807: HER3 is an actionable target in advanced prostate cancer

Free
Susana Miranda, Veronica Gil, Ruth Riisnaes, Bora Gurel, Mariantonietta D’Ambrosio, Alessandro Vasciaveo, Mateus Crespo, Ana Ferreira, Daniela Brina, Martina Troiani, Adam Sharp, Beshara Sheehan, Rossitza Christova, George Seed, Ines Figueiredo, Maryou Lambros, David Dolling, Jan Rekowski, Abdullah Alajati, Matthew Clarke, Rita Pereira, Penny Flohr, Gemma Fowler, Gunther Boysen, Semini Sumanasuriya, Diletta Bianchini, Pasquale Rescigno, Caterina Aversa, Nina Tunariu, Christina Guo, Alec Paschalis, Claudia Bertan, Lorenzo Buroni, Jian Ning, Suzanne Carreira, Paul Workman, Amanda Swain, Andrea Califano, Michael M. Shen, Andrea Alimonti, Antje Neeb, SU2C/PCF International Prostate Cancer Dream Team, Jonathan Welti, Wei Yuan, Johann de Bono
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 2807.
https://doi.org/10.1158/1538-7445.AM2022-2807
Published: 15 June 2022
View articletitled, Abstract 2807: HER3 is an actionable target in advanced prostate cancer
Journal Articles

HER3 Is an Actionable Target in Advanced Prostate Cancer

Open Access
Veronica Gil, Susana Miranda, Ruth Riisnaes, Bora Gurel, Mariantonietta D’Ambrosio, Alessandro Vasciaveo, Mateus Crespo, Ana Ferreira, Daniela Brina, Martina Troiani, Adam Sharp, Beshara Sheehan, Rossitza Christova, George Seed, Ines Figueiredo, Maryou Lambros, David Dolling, Jan Rekowski, Abdullah Alajati, Matthew Clarke, Rita Pereira, Penny Flohr, Gemma Fowler, Gunther Boysen, Semini Sumanasuriya, Diletta Bianchini, Pasquale Rescigno, Caterina Aversa, Nina Tunariu, Christina Guo, Alec Paschalis, Claudia Bertan, Lorenzo Buroni, Jian Ning, Suzanne Carreira, Paul Workman, Amanda Swain, Andrea Califano, Michael M. Shen, Andrea Alimonti, Antje Neeb, PCF/SU2C International Prostate Cancer Dream Team, Jonathan Welti, Wei Yuan, Johann de Bono
Journal: Cancer Research
Cancer Res (2021) 81 (24): 6207–6218.
https://doi.org/10.1158/0008-5472.CAN-21-3360
Published: 15 December 2021
View articletitled, HER3 Is an Actionable Target in Advanced Prostate Cancer
Open the PDF for HER3 Is an Actionable Target in Advanced Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant

Free
Abdullah Alajati, Nina Sausgruber, Nicola Aceto, Stephan Duss, Sophie Sarret, Hans Voshol, Debora Bonenfant, Mohamed Bentires-Alj
Journal: Cancer Research
Cancer Res (2013) 73 (17): 5320–5327.
https://doi.org/10.1158/0008-5472.CAN-12-3186
Published: 02 September 2013
View articletitled, Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant
Open the PDF for Mammary Tumor Formation and Metastasis Evoked by a HER2 Splice Variant in another window
Includes: Supplementary data